March 17, 2017 / 9:42 AM / 6 months ago

BRIEF-Sun Pharma Industries says Canadian unit to acquire Thallion Pharma

March 17 (Reuters) - Sun Pharmaceutical Industries Ltd

* Says deal for c$2.3 million

* Taro Pharmaceuticals Inc. (Canada) entered into deal to acquire all issued and outstanding shares of Thallion Pharma

* Consideration would be in cash

* Post deal, no turnover expected of existing products as all revenue-producing assets have been transferred from Thallion to Bellus Health

* Post acquisition of Thallion, Taro Pharma would have only rights for development of orphan drug candidate, Shigamab

* No material effect of acquisition by Taro Pharmaceuticals (Canada) on consol revenue, expenses or profits of co Source text: (bit.ly/2mPFQdh) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below